Skip to main content
. 2011 Feb 21;3(2):148–157. doi: 10.18632/aging.100273

Table 1. Effect of metformin given at the various age on age-related dynamics of estrous functional parameters in SHR mice.

Age, months No. of mice Length of estrous cycle, days Rate of estrous cycles of various length, % Fraction of mice with regular cycles, %
< 5 days 5-7 days > 7 days
Control
3 30 6.9 ± 0.28 0 64 36 81
7 29 8.1 ± 0.46 0 44 56 56
11 36 7.5 ± 0.50 0 44 56 50
14-15 24 7.4 ± 0.56 0 71 29 29
18 23 8.1 ± 0.56 0 33 67 39
21 21 8.0 ± 0.49 0 25 75 19
Metformin, 3 months
3 33 7.1 ± 0.26 0 64 36 92
7 32 6.5 ± 0.24 ** 3 74 * 23 * 92,5 ***
11 30 6.2 ± 0.31 * 27 50 23 * 84 **
14-15 24 6.4 ± 0.34 3,7 81,5 14,8 87 **
18 20 7.7 ± 0.52 0 40 60 50
21 14 6.5 ± 0.37 * 0 75 25 43
Metformin, 9 months
11 32 6.1 ± 0.30 * 22 56 22 * 80 **
14-15 29 6.6 ± 0.32 7 76 17 81**
18 22 7.7 ± 0.41 0 50 50 50
21 12 7.7 ± 1.37 0 67 33 25
Metformin, 15 months
18 19 7.6 ± 0.37 0 50 50 42
21 13 6.4 ± 0.50 * 0 87 * 13 * 54*

The difference with the controls of corresponding age is significant: * p < 0.05; ** p < 0.01; *** p < 0.001.